Essential Metabolic Routes as a Way to ESKAPE from Antibiotic Resistance

Abstract

The antibiotic resistance is a worldwide concern and that requires a concerted action from physicians, patients, governmental agencies and academia to prevent infections and the spread of resistance, to track resistant bacteria, to improve the use of current antibiotics and to develop new antibiotics. Despite the efforts spent so far, the current antibiotics in the market are restricted to only five general targets/pathways highlighting the need for basic research focusing on the discovery and evaluation of new potential targets. Here we interrogate two biosynthetic pathways as potentially druggable pathways in bacteria. The biosynthesis pathway for thiamine (vitamin B1), absent in humans, but found in many bacteria, including pathogenic organism in the group of the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa and Enterobacter species) and the biosynthesis pathway for pyridoxal 5'phosphate and its vitamers (vitamin B6), found in S. aureus. Using current genomic data, we discuss the possibilities of inhibition of enzymes in the pathway and review the current state of the art in the scientific literature.

Essential Metabolic Routes as a Way to ESKAPE From Antibiotic Resistance

“…Santos, Lívia Regina M. Margarido, Josimar Sartori, and João Fernando Possatto for their technical support. This manuscript has been released as a Pre-Print at BioRxiv (53).…”